U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07211490) titled 'rTMS for Cerebellar Ataxia in Children' on Oct. 02.
Brief Summary: Dysfunction of the cerebellum can result in cerebellar ataxia (CA), typically marked by symptoms such as movement incoordination, gait instability, articulation disorder, oculomotor and swallowing difficulties. Children affected by paediatric cerebellar ataxia (PCA) often suffer from an array of motor symptoms, affecting their quality of life and psychosocial well-being. It was estimated that PCA affects 26/100,000 children worldwide for both genetic and acquired causes. Epidemiological data on PCA, however, are absent in the Hong Kong population.
PCAs comprise a var...